These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 6679787

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cyclophosphamide, 2,2-dimethylaziridines and other alkylating agents as inhibitors of serum cholinesterase.
    Lalka D, Bardos TJ.
    Biochem Pharmacol; 1975 Feb 15; 24(4):455-6. PubMed ID: 1167458
    [No Abstract] [Full Text] [Related]

  • 4. [Catalytic properties of cholinesterases immobilized in N-phthalylchitosan and gelatin].
    Kuznetsova LP, Nikol'skaia EB.
    Ukr Biokhim Zh (1978); 1995 Feb 15; 67(5):49-54. PubMed ID: 8830436
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Binding sites of cholinesterases. Alkylation by an aziridinium derivative.
    O'Brien RD.
    Biochem J; 1969 Jul 15; 113(4):713-9. PubMed ID: 5386194
    [Abstract] [Full Text] [Related]

  • 7. [Interaction between various cholinesterases and reversible inhibitors of polymethylene-bis-(trimethylammonium) diiodide series].
    Brestkin AP, Viniar TN, Rozengart EV.
    Ukr Biokhim Zh (1978); 1983 Jul 15; 55(1):77-9. PubMed ID: 6600861
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of carbodiimides on the catalytic properties of cholinesterases].
    Volkova RI, Kochetova LM.
    Biokhimiia; 1981 Oct 15; 46(10):1823-31. PubMed ID: 6946838
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Estimation of cholinesterase activity (EC 3.1.1.7; 3.1.1.8) in undiluted plasma and erythrocytes as a tool for measuring in vivo effects of reversible inhibitors.
    Thomsen T, Kewitz H, Pleul O.
    J Clin Chem Clin Biochem; 1988 Jul 15; 26(7):469-75. PubMed ID: 3065439
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Specificity of interaction with acetylcholinesterase and butyrylcholinesterase of choline analogs based on ephedrine and pseudoephedrine].
    Dalimov DN, Vaĭzburg GM, Abdullaeva LK, Abduvakhabov AA, Sadykov AS.
    Dokl Akad Nauk SSSR; 1986 Jul 15; 289(1):227-30. PubMed ID: 3732039
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Interaction of bis-phosphorylated methanes with mammalian esterases].
    Makhaeva GF, Shataeva GA, Iankovskaia VL, Fetisov VI, Loshadkin NA.
    Bioorg Khim; 1984 Oct 15; 10(10):1347-52. PubMed ID: 6517964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.